Infectious Disease

Infectious Disease

UAB researchers have proposed a paradigm shifting and innovative inhaled probiotic therapy for treatment of lung diseases to inhibit inflammation and restore lung function.

Treatment of acute and chronic lung diseases

Infectious Disease

Commercialization of a discovery by UAB researchers will lead to a novel patented-protected pneumococcal vaccine with greatly enhanced efficacy.

Discovery and characterization of new pneumococcal group 6 serotype which, in a vaccine, elicits protection against S. pneumoniae 6C and 6D

Infectious Disease

Researchers at UAB have developed biofilm inhibitors that selectively inhibit biofilm formation by the major etiological agent in tooth decay, Streptococcus mutans (S. mutans), without affecting the growth of healthy oral commensal bacteria.

Prevention of tooth decay